Non-nutritive sweeteners (NNS) have seen increasingly common usage amongst foodstuffs in the westernized diet in the past few decades, including processed foods and flavored beverages. Recently, an increasing body of research has been evaluating the potential of NNS for alternative uses in healthcare and medicine. Some of these sweeteners, such as stevioside, have been implicated as being anti-hypertensive, anti-carcinogenic, and anti-inflammatory in several contexts. To examine the potential of NNS such as stevioside as an anti-carcinogenic agent, cellular behavior of HFF-1 human foreskin fibroblasts (ATCC SCRC-1041) & COLO-829 human melanoma fibroblasts (ATCC CRL-1974) was observed in the presence of sucrose, sucralose, and stevioside on collagen. This study examined the impact of NNS on initial adhesion, cellular proliferation, and integrin expression on healthy and cancerous fibroblast cell lines. The results indicate that 5 mg/mL stevioside caused more than 2-fold decrease in the initial adhesion of healthy cells but caused more than 4-fold increase in the initial adhesion of cancerous cells. In terms of proliferation, stevioside at 5 mg/mL caused a 13-fold decrease in cancer cell proliferation, proportional to concentration, but a 1.5-fold increase in proliferation for healthy cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.